4.7 • 6K Ratings
🗓️ 15 September 2023
⏱️ 13 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | You're listening to Shorewave from NPR. |
0:05.4 | Hey, Shorewaveers, Regina Barber here, with news that there's a new COVID vaccine on |
0:09.5 | its way to pharmacies. |
0:11.3 | The FDA approved the shots this week and a day later, the CDC weighed in on who should |
0:15.9 | get it. |
0:16.9 | So we figured it's time to call up our colleagues Rob Stein, and Marie Godoy, hey, Chica. |
0:23.3 | And we're here to talk all things booster vaccines, especially this booster. |
0:27.5 | It was initially developed with the Omicron Subvariant XBB15 in mind, and in the middle |
0:32.7 | of developing this vaccine, a new subvariant of Omicron emerged. |
0:36.7 | BA286. |
0:37.7 | Right. |
0:38.7 | And scientists were watching BA286 closely when it popped up in August and continued to |
0:44.3 | keep an eye on it because it contains more than 30 mutations on the spike protein the |
0:49.3 | virus uses to infect cells, which is a level of mutation on par with the original Omicron |
0:54.9 | variant that caused a massive surge. |
0:58.3 | And there has been a surge recently. |
1:00.5 | Yep. |
1:01.5 | Hospitalizations have jumped. |
1:02.9 | Some hospitals in schools have reinstated mass requirements, or at least actively encourage |
1:07.8 | people to wear them again. |
1:09.6 | But the experts that Rob and I have spoken to have said so far, this latest subvariant |
1:14.4 | is not better at evading vaccines. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from NPR, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of NPR and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.